Financhill
Back

Acumen Pharmaceuticals Quote, Financials, Valuation and Earnings

Acumen Pharmaceuticals Price Quote

$2.84
-0.01 (-1.39%)
(Updated: November 2, 2024 at 6:09 AM ET)

Acumen Pharmaceuticals Key Stats

Sell
47
Acumen Pharmaceuticals (ABOS) is a Sell

Day range:
$2.79 - $2.94
52-week range:
$1.81 - $5.09
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.7%

Volume:
104.4K
Avg. volume:
186.8K
1-year change:
49.74%
Market cap:
$170.9M
Revenue:
$0
EPS:
$-1.12

How Much Does Acumen Pharmaceuticals Make?

Data Unavailable

Is Acumen Pharmaceuticals Growing As A Company?

Data Unavailable

Acumen Pharmaceuticals Stock Price Performance

What Is Acumen Pharmaceuticals 52-Week High & Low?

Acumen Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Acumen Pharmaceuticals?

Is Acumen Pharmaceuticals Cash Flow Positive?

  • What Is ABOS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$55.6M
  • What Is Acumen Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $158.9M
  • What Is Acumen Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$112.3M

Acumen Pharmaceuticals Return On Invested Capital

Data Unavailable

Acumen Pharmaceuticals Earnings Date & Stock Price

Acumen Pharmaceuticals Competitors

Acumen Pharmaceuticals Dividend Yield

Acumen Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -35.33%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 11.20
Upside from Last Price: 293.67%

Major Shareholders

  • How many ABOS shares are owned by institutional investors?
    56.2M ABOS shares are owned by institutional investors
  • How many ABOS shares are owned by insiders?
    1.2M ABOS shares are owned by insiders